The SPLIT leadership recognized the need for real-time exchange of pediatric data in this unprecedented time. In that spirit we are partnering with IIRTA to develop a listserv to help track and address both COVID 19 related queries as well as general discussions related to the care of hepatology, pre- and post-liver and intestinal transplant patients.

To date, we are aware of 4 pediatric liver transplant recipients in North America who are COVID positive; inevitably there are more. The strength of our pediatric liver and intestinal transplant community is the accessibility of its diverse and robust expertise.  We are particularly grateful to the openness and generosity of our trailblazing colleagues in New York in sharing their early experiences and management approaches with our community to-date.  We now invite you to share your experiences in recognizing and treating COVID, as we can all learn from each other.

• To allow for general discussion amongst partners who care for children with liver disease or liver and intestinal transplant recipients
• To create a forum for our community as you may begin to see an influx of COVID positive transplant registrants or recipients
• To enable discussion related to your institutional practices on: donor and recipient COVID testing, immunosuppression minimization for COVID positive patients, use of medical therapies for COVID in collaboration with our pediatric transplant infectious disease colleagues